Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

A pilot trial of injectable, extended-release naltrexone for the treatment of co-occurring cocaine and alcohol dependence.

Pettinati HM, Kampman KM, Lynch KG, Dundon WD, Mahoney EM, Wierzbicki MR, O'Brien CP.

Am J Addict. 2014 Nov;23(6):591-7. doi: 10.1111/j.1521-0391.2014.12146.x. Epub 2014 Sep 22.

PMID:
25251201
[PubMed - in process]
2.

Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.

Winhusen TM, Kropp F, Lindblad R, Douaihy A, Haynes L, Hodgkins C, Chartier K, Kampman KM, Sharma G, Lewis DF, VanVeldhuisen P, Theobald J, May J, Brigham GS.

J Clin Psychiatry. 2014 Jul;75(7):757-64. doi: 10.4088/JCP.13m08862.

PMID:
24911028
[PubMed - indexed for MEDLINE]
3.

The effects of quetiapine on sleep in recovering alcohol-dependent subjects: a pilot study.

Chakravorty S, Hanlon AL, Kuna ST, Ross RJ, Kampman KM, Witte LM, Perlis ML, Oslin DW.

J Clin Psychopharmacol. 2014 Jun;34(3):350-4. doi: 10.1097/JCP.0000000000000130.

PMID:
24747978
[PubMed - in process]
4.

Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues.

Young KA, Franklin TR, Roberts DC, Jagannathan K, Suh JJ, Wetherill RR, Wang Z, Kampman KM, O'Brien CP, Childress AR.

J Neurosci. 2014 Apr 2;34(14):5038-43. doi: 10.1523/JNEUROSCI.4977-13.2014.

PMID:
24695721
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.

Kranzler HR, Covault J, Feinn R, Armeli S, Tennen H, Arias AJ, Gelernter J, Pond T, Oncken C, Kampman KM.

Am J Psychiatry. 2014 Apr 1;171(4):445-52. doi: 10.1176/appi.ajp.2013.13081014. Erratum in: Am J Psychiatry. 2014 May 1;171(5):585.

PMID:
24525690
[PubMed - indexed for MEDLINE]
6.

The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.

Clarke TK, Weiss AR, Ferarro TN, Kampman KM, Dackis CA, Pettinati HM, O'brien CP, Oslin DW, Lohoff FW, Berrettini WH.

Ann Hum Genet. 2014 Jan;78(1):33-9. doi: 10.1111/ahg.12046. Epub 2013 Nov 25.

PMID:
24359476
[PubMed - indexed for MEDLINE]
7.

Biomarkers for the development of new medications for cocaine dependence.

Bough KJ, Amur S, Lao G, Hemby SE, Tannu NS, Kampman KM, Schmitz JM, Martinez D, Merchant KM, Green C, Sharma J, Dougherty AH, Moeller FG.

Neuropsychopharmacology. 2014 Jan;39(1):202-19. doi: 10.1038/npp.2013.210. Epub 2013 Aug 27.

PMID:
23979119
[PubMed - in process]
8.

Results from a pilot clinical trial of varenicline for the treatment of alcohol dependence.

Plebani JG, Lynch KG, Rennert L, Pettinati HM, O'Brien CP, Kampman KM.

Drug Alcohol Depend. 2013 Dec 1;133(2):754-8. doi: 10.1016/j.drugalcdep.2013.06.019. Epub 2013 Jul 31.

PMID:
23916324
[PubMed - indexed for MEDLINE]
9.

A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.

Kampman KM, Pettinati HM, Lynch KG, Spratt K, Wierzbicki MR, O'Brien CP.

Drug Alcohol Depend. 2013 Nov 1;133(1):94-9. doi: 10.1016/j.drugalcdep.2013.05.026. Epub 2013 Jun 28.

PMID:
23810644
[PubMed - indexed for MEDLINE]
10.

Case-control association study of WLS variants in opioid and cocaine addicted populations.

Crist RC, Ambrose-Lanci LM, Zeng A, Yuan C, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Ferraro TN, Doyle GA, Lohoff FW, Berrettini WH.

Psychiatry Res. 2013 Jun 30;208(1):62-6. doi: 10.1016/j.psychres.2013.03.011. Epub 2013 Apr 5.

PMID:
23566366
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Clarke TK, Crist RC, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Ferraro TN, Lohoff FW, Berrettini WH.

Neurosci Lett. 2013 May 10;542:71-5. doi: 10.1016/j.neulet.2013.02.018. Epub 2013 Feb 20.

PMID:
23454283
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Neuronal calcium sensor-1 and cocaine addiction: a genetic association study in African-Americans and European Americans.

Multani PK, Clarke TK, Narasimhan S, Ambrose-Lanci L, Kampman KM, Pettinati HM, Oslin DW, O'Brien CP, Berrettini WH, Lohoff FW.

Neurosci Lett. 2012 Nov 30;531(1):46-51. doi: 10.1016/j.neulet.2012.09.014. Epub 2012 Sep 20.

PMID:
22999924
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, Ferraro TN, Hakonarson H, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Doyle GA, Lohoff FW, Berrettini WH.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):122-8. doi: 10.1016/j.drugalcdep.2012.06.023. Epub 2012 Jul 12.

PMID:
22795689
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction.

Clarke TK, Ambrose-Lanci L, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Genes Brain Behav. 2012 Jun;11(4):415-23. doi: 10.1111/j.1601-183X.2012.00785.x. Epub 2012 Apr 11.

PMID:
22443215
[PubMed - indexed for MEDLINE]
15.

A double-blind, placebo-controlled trial of modafinil for cocaine dependence.

Dackis CA, Kampman KM, Lynch KG, Plebani JG, Pettinati HM, Sparkman T, O'Brien CP.

J Subst Abuse Treat. 2012 Oct;43(3):303-12. doi: 10.1016/j.jsat.2011.12.014. Epub 2012 Feb 27.

PMID:
22377391
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Expanding applications of deep brain stimulation: a potential therapeutic role in obesity and addiction management.

Halpern CH, Torres N, Hurtig HI, Wolf JA, Stephen J, Oh MY, Williams NN, Dichter MA, Jaggi JL, Caplan AL, Kampman KM, Wadden TA, Whiting DM, Baltuch GH.

Acta Neurochir (Wien). 2011 Dec;153(12):2293-306. doi: 10.1007/s00701-011-1166-3. Review.

PMID:
21976235
[PubMed - indexed for MEDLINE]
17.

Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.

Plebani JG, Lynch KG, Yu Q, Pettinati HM, O'Brien CP, Kampman KM.

Drug Alcohol Depend. 2012 Feb 1;121(1-2):163-6. doi: 10.1016/j.drugalcdep.2011.08.025. Epub 2011 Sep 16.

PMID:
21925806
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis.

Stephen JH, Halpern CH, Barrios CJ, Balmuri U, Pisapia JM, Wolf JA, Kampman KM, Baltuch GH, Caplan AL, Stein SC.

Addiction. 2012 Mar;107(3):624-34. doi: 10.1111/j.1360-0443.2011.03656.x. Review.

PMID:
21919988
[PubMed - indexed for MEDLINE]
19.

Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis.

Clarke TK, Bloch PJ, Ambrose-Lanci LM, Ferraro TN, Berrettini WH, Kampman KM, Dackis CA, Pettinati HM, O'Brien CP, Oslin DW, Lohoff FW.

Addict Biol. 2013 Jul;18(4):702-8. doi: 10.1111/j.1369-1600.2011.00346.x. Epub 2011 Jul 25.

PMID:
21790903
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.

Kampman KM, Dackis C, Pettinati HM, Lynch KG, Sparkman T, O'Brien CP.

Addict Behav. 2011 Mar;36(3):217-21. doi: 10.1016/j.addbeh.2010.11.003. Epub 2010 Nov 10.

PMID:
21112155
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk